HomeCompareTHRD vs NNN

THRD vs NNN: Dividend Comparison 2026

THRD yields 37.17% · NNN yields 5.68%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 THRD wins by $173.0K in total portfolio value
10 years
THRD
THRD
● Live price
37.17%
Share price
$5.38
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$198.5K
Annual income
$31,557.09
Full THRD calculator →
NNN
NNN REIT Inc.
● Live price
5.68%
Share price
$41.89
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.6K
Annual income
$2,637.42
Full NNN calculator →

Portfolio growth — THRD vs NNN

📍 THRD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTHRDNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, THRD + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
THRD pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

THRD
Annual income on $10K today (after 15% tax)
$3,159.85/yr
After 10yr DRIP, annual income (after tax)
$26,823.53/yr
NNN
Annual income on $10K today (after 15% tax)
$482.93/yr
After 10yr DRIP, annual income (after tax)
$2,241.81/yr
At 15% tax rate, THRD beats the other by $24,581.72/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of THRD + NNN for your $10,000?

THRD: 50%NNN: 50%
100% NNN50/50100% THRD
Portfolio after 10yr
$112.1K
Annual income
$17,097.26/yr
Blended yield
15.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

THRD
Analyst Ratings
1
Buy
4
Hold
Consensus: Hold
Price Target
$16.15
+200.2% upside vs current
Range: $3.60 — $23.00
Altman Z
19.7
Piotroski
1/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+7.3% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

THRD buys
0
NNN buys
0
No recent congressional trades found for THRD or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTHRDNNN
Forward yield37.17%5.68%
Annual dividend / share$2.00$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$198.5K$25.6K
Annual income after 10y$31,557.09$2,637.42
Total dividends collected$146.1K$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldHold
Analyst price target$16.15$44.93

Year-by-year: THRD vs NNN ($10,000, DRIP)

YearTHRD PortfolioTHRD Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$14,417$3,717.47$10,737$617.02+$3.7KTHRD
2$20,436$5,009.02$11,577$710.93+$8.9KTHRD
3$28,502$6,635.45$12,538$822.59+$16.0KTHRD
4$39,146$8,649.01$13,645$956.06+$25.5KTHRD
5$52,988$11,101.91$14,925$1,116.51+$38.1KTHRD
6$70,742$14,044.48$16,415$1,310.57+$54.3KTHRD
7$93,217$17,523.45$18,158$1,546.77+$75.1KTHRD
8$121,322$21,580.22$20,213$1,836.20+$101.1KTHRD
9$156,064$26,249.33$22,649$2,193.37+$133.4KTHRD
10$198,546$31,557.09$25,558$2,637.42+$173.0KTHRD

THRD vs NNN: Complete Analysis 2026

THRDStock

Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.

Full THRD Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this THRD vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

THRD vs SCHDTHRD vs JEPITHRD vs OTHRD vs KOTHRD vs MAINTHRD vs ADCTHRD vs EPRTTHRD vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.